Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 1998
View Archived Issues
YM-337 shows therapeutic potential for the treatment of coronary thrombosis
Read More
Company Profile: Rigel
Read More
Resveratrol has a direct antiproliferative effect against breast cancer cells
Read More
Rights to bgh gene tool available from RCT
Read More
Sequus and Faulding sign marketing agreement for Amphotec
Read More
Company Profile: AEterna
Read More
Connetics: Q1 1998 highlights
Read More
Transgene: Q1 1998 highlights
Read More
Bionutrics to acquire Lipoprotein and its cholesterol-lowering drug candidate
Read More
Genset: Q1 1998 highlights
Read More
Purepac to market generic etodolac 500-mg tablets
Read More
BCX-140, an aromatic inhibitor of influenza neuraminidase
Read More
Zadaxin decreases formation of lung tumors in mice
Read More
IntraDose injectable gel shows promise in phase I/II
Read More
Azimilide: a unique new antiarrhythmic agent in phase III development
Read More
FDA grants approval for pivotal clinical trial of Repel
Read More
Enzo, Hadassah University collaborate on immunomodulating technology
Read More
High priority given to linezolid development at Pharmacia & Upjohn
Read More
Akorn launches generic cromolyn sodium
Read More
First market introduction for basiliximab
Read More
Selective somatostatin receptor antagonist reported for pancreatic disorders
Read More
Therapeutic Antibodies seeks FDA approval for antivenom product
Read More
DAB389IL-7, a novel fusion protein for the specific elimination of IL-7 receptor-positive cells
Read More
Novartis begins phase III trial with Aredia in prostate cancer patients
Read More
Ligand to merge with Seragen and acquire Marathon; acquires fusion toxin rights from Lilly
Read More
Immune Network Research reports on progress of primate study evaluating 1F7 for HIV
Read More
Pharmacia & Upjohn submits NDA for Edronax
Read More
XR-9576 enters clinical testing
Read More
IRL-3630: a bifunctional ET antagonist for respiratory ailments
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe